Sachdeva et al. illustrated that genetic knockout of ID1 or treatment with the antipsychotic drug pimozide can decrease EGFR activation, reduce tumor growth, and potentiate the effects of TMZ therapy [136]. This evidence concerns the gene EGFR and neoplasm.